Articles
The diagnostic and therapeutic potential of nanomedicine should result in an acceleration of its development in the following years. Alcimed goes back over the 4 main fields of application of ...
Healthcare
Following the International Rare Disease Day, Alcimed invites you to dive into the rare diseases’ universe, with a focus on patients and patient associations. To understand how they have become ...
Cross-sector
How can artificial intelligence benefit language preservation? Artificial intelligence (AI) makes it possible, through various applications, to preserve endangered languages and to decipher ancient ...
Articles
Zydus Cadila became the first pharmaceutical company to obtain a marketing authorization for Saroglitazar, a drug indicated for non-alcoholic steatosis of the liver (NASH), after getting the green ...
Articles
Tumor agnostic treatments are a very new development in the exciting field of personalized medicine. These drugs can be applied to tumors of any type targeting specific genomic anomalies or molecular ...
Presse
Géradline Börtlein, co-founder of Alcimed and Vice-President of the Association of innovation consulting firms (ACI: Association des Conseils en Innovation), presents the concept of innovation ...
Healthcare
The difficulty to come up with therapeutic solutions for rare diseases, the emergence of resistance to certain drugs or pressure on the price of drugs urge pharma companies to rethink their R&D ...
Articles
Mass Customization (MC) is becoming a significant market trend, notably in the food industry. MC can be applied to extrinsic characteristics like packaging and design but also to intrinsic elements ...
Cross-sector
Since the 2000s, scientific interest in the microbiota has been growing steadily, particularly in the United States and Europe. After the intestinal microbiota success, bacteria and other ...
Healthcare
Cancer will soon be death cause number 1 on a global level representing strong unmet medical needs and enormous costs for healthcare systems. New, innovative treatments and technologies as well as ...